Maud Rothärmel

4PUBLICATIONS
7CO-AUTHORS
Testing, assessment and psychometricsGene and molecular therapyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 01, 2026
Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.

Maud Rothärmel, Lila Mekaoui, François Kazour

|Jan 25, 2026
A prospective multicentre double-blind randomized controlled trial evaluating clinical, cognitive and neural effects of potentiation of electroconvulsive therapy by repetitive transcranial magnetic stimulation in patients with treatment-resistant depression (STIMAGNECT 2).

Léa Clabeau, Virginie Moulier, Bastien Kaczmarek

|Apr 14, 2025
Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study.

Ludovic Samalin, Lila Mekaoui, Maud Rothärmel

|Apr 16, 2021
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).

Virginie Moulier, Mohamed Wassim Krir, Marine Dalmont

Pageof 1

Frequent Collaborators

1 joint publications

Ludovic Samalin

1 joint publications

Lila Mekaoui

1 joint publications

Anne Sauvaget

1 joint publications

Clotilde Wicart